日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

Vaccination strategies when vaccines are scarce: on conflicts between reducing the burden and avoiding the evolution of escape mutants

MPS-Authors
/persons/resource/persons269567

Geoffroy,  Félix
Research Group Stochastic Evolutionary Dynamics, Department Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Max Planck Society;

/persons/resource/persons56973

Traulsen,  Arne
Department Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Max Planck Society;

/persons/resource/persons214490

Uecker,  Hildegard
Research Group Stochastic Evolutionary Dynamics, Department Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Max Planck Society;

External Resource
There are no locators available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)

rsif.2022.0045.pdf
(出版社版), 958KB

付随資料 (公開)
There is no public supplementary material available
引用

Geoffroy, F., Traulsen, A., & Uecker, H. (2022). Vaccination strategies when vaccines are scarce: on conflicts between reducing the burden and avoiding the evolution of escape mutants. Interface: Journal of the Royal Society, 19:. doi:10.1098/rsif.2022.0045.


引用: https://hdl.handle.net/21.11116/0000-000B-27DF-F
要旨
When vaccine supply is limited but population immunization urgent, theallocation of the available doses needs to be carefully considered. Oneaspect of dose allocation is the time interval between the first and thesecond injections in two-dose vaccines. By stretching this interval, more indi-viduals can be vaccinated with the first dose more quickly, which can bebeneficial in reducing case numbers, provided a single dose is sufficientlyeffective. On the other hand, there has been concern that intermediatelevels of immunity in partially vaccinated individuals may favour theevolution of vaccine escape mutants. In that case, a large fraction of half-vaccinated individuals would pose a risk—but only if they encounter thevirus. This raises the question whether there is a conflict between reducingthe burden and the risk of vaccine escape evolution or not. We develop anSIR-type model to assess the population-level effects of the timing of thesecond dose. Trade-offs can occur both if vaccine escape evolution is morelikely or if it is less likely in half-vaccinated than in unvaccinated individ-uals. Their presence or absence depends on the efficacies for susceptibilityand transmissibility elicited by a single dose.